Q. M. Anstee Et Al. , "Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study," Hepatology , vol.78, no.4, pp.1223-1239, 2023
Anstee, Q. M. Et Al. 2023. Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study. Hepatology , vol.78, no.4 , 1223-1239.
Anstee, Q. M., Lucas, K. J., Francque, S., Abdelmalek, M. F., Sanyal, A. J., Ratziu, V., ... Gadano, A. C.(2023). Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study. Hepatology , vol.78, no.4, 1223-1239.
Anstee, Quentin Et Al. "Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study," Hepatology , vol.78, no.4, 1223-1239, 2023
Anstee, Quentin M. Et Al. "Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study." Hepatology , vol.78, no.4, pp.1223-1239, 2023
Anstee, Q. M. Et Al. (2023) . "Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study." Hepatology , vol.78, no.4, pp.1223-1239.
@article{article, author={Quentin M. Anstee Et Al. }, title={Tropifexor plus cenicriviroc combination versus monotherapy in nonalcoholic steatohepatitis: Results from the phase 2b TANDEM study}, journal={Hepatology}, year=2023, pages={1223-1239} }